Business, Free News Articles

World Renowned Patient Safety Champion Joins CAREier Advisory Board

POTOMAC, Md. -- CAREier, Inc., the revolutionary medical device communication company, is building an advisory board of patient safety and healthcare industry powerhouses. Its latest addition is world renowned, Peter J. Pronovost, M.D., Ph.D., F.C.C.M., a critical care physician and prolific researcher who has published more than 800 peer review publications; his scientific work has saved thousands of lives.

"We're absolutely thrilled that Dr. Pronovost has joined our advisory board," Ryan Bass, founder and CEO, CAREier says. "As a global thought leader who has influenced U.S. and global health policy, I'm confident he will help us to champion a new chapter in healthcare IT, patient safety and medical device communication."

When Bass founded CAREier, he sought to turn the world of medical device communication on its head. He didn't just want an incremental improvement to the processes used today, he wanted to change the system - and eventually the world's standards for patient level communication expectations. There's no other platform like it.

CAREier provides a framework for seamless communication across the entire medical device spectrum for an automated, immediate, and secure delivery of patient electronic device information, device recalls, standards of care reminders and more.

"We really work from the top down," Bass says. "Everyone from the FDA to the patient is part of our holistic network. And we're sure that our advisory board will help us to build a better medical device communication ecosystem. I'm truly humbled and honored to have Dr. Pronovost on board."

In 2005, Dr. Pronovost was involved in the launch of a leading solution to the medical device communication problem and since then, he says he hasn't seen any real innovation - that is - until now.

"Almost 20 years ago, I was involved in developing systems and processes related to the recalls experienced by health systems. Since then, innovation in this space has been slow and I was excited when CAREier approached me with their pioneering solution. CAREier is not an incremental improvement to today's workflows, but is a transformative approach to more efficiently and effectively manage recalls and improve safety."

About Peter J. Pronovost, M.D., Ph.D., F.C.C.M.:

Dr. Pronovost is the Chief Quality and Clinical Transformation Officer at University Hospitals. His entrepreneurial patient safety endeavors have earned him high-profile accolades - including being named one of the 100 most influential people in the world by "Time" magazine, receiving a coveted MacArthur Foundation "genius grant" in 2008.

In his current role, he fosters ideation and implementation for new protocols to eliminate defects in value to enhance quality of care; develop new frameworks for population health management for its more than 1 million patients; and manage the UH Accountable Care Organization (ACO) Network - one of the nation's largest. His primary focus is to keep people "Healthy at Home." In just 12 months, one of his concepts fueled a reduction in annual costs per patient in the UH ACO by nine percent.

He's also served as the senior vice president for Patient Safety and Quality at Johns Hopkins Medicine as well as the founder and director of the Johns Hopkins Medicine Armstrong Institute for Patient Safety and Quality. While there, he worked to eliminate all harms in one health system following on his success in eliminating one harm in most health systems across the U.S.

For a complete bio:

About CAREier:

CAREier is revolutionizing medical device communications to finally include the patient. Its mission is to create a complete communication ecosystem between regulators, medical device manufacturers, healthcare providers, physicians and patients to transmit urgent messages in near real-time with confirmed receipt and acknowledgement.

For more information:

Related link:

This news story was published by the Neotrope® News Network - all rights reserved. ID:NEO2022

Alliances and Partnerships, Business, Free News Articles

Dosaggio by SottoPelle Partners with Cerbo

SCOTTSDALE, Ariz. -- Dosaggio™ by SottoPelle® and Cerbo announced today that they have entered into a partnership that integrates the two companies' innovative technologies, to improve efficiencies and elevate patient care for providers offering bioidentical hormone replacement therapy (BHRT).

Dosaggio™, the original, multi-patented hormone therapy dosing platform for physicians, announces its exciting new partnership with Cerbo electronic health records (EMR). This collaboration offers medical providers a powerful and seamless integration of capabilities for bioidentical hormone replacement therapy practices.

This partnership brings together Cerbo's robust functional EHR with the advanced and powerful Dosaggio™ hormone dosing tool, enabling medical providers to expand their functional medicine practices into the bioidentical hormone therapy arena.

Cerbo is a functional, full-service EHR that offers customized and integrated scheduling, charting, billing, reporting, prescription management, and treatment plan solutions for medical practices. The Cerbo EHR offers flexibility for each provider's needs - all with fair pricing.

The Dosaggio™ bioidentical hormone pellet therapy dosing application allows medical providers to optimize their patient's hormone health through precise, individualized hormone dosing. Dosaggio™ by SottoPelle® offers providers a proprietary online hormone dosing calculator that uses the patient's unique health data to calculate a precise, individualized BHRT dose. Dosaggio™ combines a powerful algorithm with on-screen clinical guidance that enables medical providers to approach each patient's hormone health care in an individualized manner.

The integration of these two platforms allows medical providers to pull patient data such as lab work, demographics, past hormone therapy notes, and other documentation from their Cerbo EHR into the Dosaggio™ dosing application. This eliminates the need for double documentation and helps seamlessly maintain continuity of care for BHRT patients.

"The Dosaggio and Cerbo integration will help providers bring quality care to their patients who suffer from hormonal imbalance," stated CarolAnn Tutera, CEO of Dosaggio™ by SottoPelle®. "It is our mission to help providers bring individualized care to more patients, to help them age gracefully."

Practices that are currently using Cerbo's EHR can conveniently set up their Dosaggio™ account by visiting the integrations page within their account.

Medical providers who are interested in learning more about this exciting integration may visit:

Learn more about SottoPelle® Therapy at:

Related link:

This news story was published by the Neotrope® News Network - all rights reserved. ID:NEO2022

Education and Schools, Free News Articles

NPA Announces Exciting DEIB Efforts During National Postdoc Appreciation Week

ROCKVILLE, Md. -- The National Postdoctoral Association (NPA) announced two marquee programs designed to advance diversity, equity, inclusion and belonging (DEIB) in the postdoctoral community and beyond. During the highly successful National Postdoc Appreciation Week, the NPA shared details on both the finalists in its 2022-2023 IMPACT Fellowship Program, as well as the first NPA Race & Ethnicity Equity Summit, a free global event taking place November 17, 2022.

"Promoting diversity, equity, inclusion and belonging is not only at the heart of our strategic planning, it is one of our core values," explained Thomas P. Kimbis, J.D., executive director and chief executive officer of the NPA. "These ground-breaking activities not only help those directly engaged in the programs, but they push hard in difficult areas across the whole scientific and research communities."

The IMPACT Fellowship Program (IMPACT) was launched last year to empower postdoctoral scholars from underrepresented backgrounds to build skills, understand strengths and develop networks. Competition for program seats in the second year of the program was intense with more than fifty applicants from across the globe for only six positions.

IMPACT Fellows will interact with experts from a range of disciplines as well as learn from one another as they strategically build upon existing skills, recognize opportunities, and advance more confidently in their careers. Fellows will also use the knowledge, tools and resources they gain from the program to implement innovative activities or initiatives at their institutions that amplify the impact of the fellowship as they contribute back to home communities.

NPA IMPACT Fellows, Class of 2022-23:

* Camilo A. Duarte-Cordon, Ph.D., Columbia University

* Phyllis Kyei Mensah, Ph.D., Utah State University

* Caleb Muefong, Ph.D., Washington University in St Louis

* Kathryn Sanchez, Ph.D., University of New Mexico

* Ricardo Velasco Trujillo, Ph.D., University of Minnesota Twin Cities

* Liisa Veerus, D.Phil., Rutgers University

The first NPA Race & Ethnicity Equity Summit was created in recognition that scientists and researchers from underrepresented communities face additional challenges and barriers that are too often disregarded. Through a series of interactive online race and ethnicity discussions featuring more than twenty expert speakers from industry, academia, government, and nonprofits, the summit seeks to identify barriers - and find paths forward - in the greater postdoctoral community on the path to greater racial and ethnic equity. Hundreds of participating scientists, researchers, and academic professionals are expected to attend.

The NPA's DEIB activities are made possible through the generosity of its sponsors, including Gallagher Insurance and the University of Chicago. The NPA is seeking additional sponsors to support underrepresented communities of scholars, promote their own diversity goals, and advance discussion and action in areas needing critical attention. Academic institutions, companies, and nonprofit funders wishing to engage with the NPA can read more about available sponsorship opportunities.

The NPA is a national charitable and educational nonprofit association headquartered in Rockville, Maryland, that seeks to improve the postdoctoral experience by supporting a culture of inclusive connection. At the individual, organizational, and national levels, the NPA facilitates enhanced professional growth, raises awareness, and collaborates with stakeholders in the postdoctoral community. Membership in the NPA is open to all organizations and individuals interested in advancing the interests of postdocs in the United States. Affiliate membership in the NPA for most postdocs is free and available at

To support NPA and its charitable mission, please visit or text 20FORNPA to 44-321.


Related link:

This news story was published by the Neotrope® News Network - all rights reserved. ID:NEO2022

Business, Education and Schools, Free News Articles, Funding and Investment

BioBuilder funded to expand student opportunity in rural and urban areas through its collaborative after school program

BOSTON, Mass. -- Thanks to a two-year grant recently awarded by BioMADE, the BioBuilder Educational Foundation will expand a program that has supported thousands of high school inventors over the last decade. BioBuilder is leading the project, "Launching High School Bioengineers on their Paths to College and Careers," with funding that will bring the authentic tools and approaches for engineering biology to BioBuilderClub students nationwide in collaboration with East Tennessee State University, Ars Biotechnica, and Daicel Arbor Biosciences.

Support from BioMADE will enable these organizations to provide teams of young innovators new opportunities to design, build and test their biodesigns, and submit their research for publication as peer-reviewed manuscripts in BioTreks (Ars Biotechnica). Industry-standard biomanufacturing reagents and mentorship from professional scientists will be provided by Daicel Arbor, while East Tennessee State University will expand the geographic and demographic reach of the BioBuilderClub and spearhead a rigorous evaluation of its impact.

Thomas Tubon, Chief Workforce Development Officer for BioMADE said, "With the bioeconomy expected to contribute over a million jobs in this field by 2030, and the growing desire to connect local feedstocks to nearby manufacturing capabilities, a program like this is essential as it can raise awareness and provide opportunities to students, regardless of geography or demography."

Founder and Executive Director of BioBuilder, Dr. Natalie Kuldell shared that, "We are thrilled to be building momentum in non-traditional STEM hubs. By simultaneously training students and celebrating their achievements, this work will draw students into the exciting and creative sides of science and engineering. It will also increase awareness among community stakeholders, including parents of participating students, high school teachers, college admissions officers, and relevant local businesses."

These goals are fully aligned with the recently signed Executive Order on Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure American Bioeconomy that establishes the National Biotechnology and Biomanufacturing Initiative. The National Biotechnology and Biomanufacturing Initiative will create jobs, leverage biotechnology to build more resilient supply chains, improve health outcomes, and lower prices for Americans by expanding biomanufacturing capacity, creating market pathways for bio-based products, training a diverse workforce, and fostering innovation.

About BioBuilder:

Created by an award-winning team from MIT, BioBuilder empowers teachers and schools to better serve students and employers by elevating the skills that students are taught. Founded in 2011, BioBuilder has grown to partner with schools in almost every state and around the world. BioBuilder builds confidence in teachers to learn and apply the synthetic biology curricula, and provides laboratory kits and an openly accessible textbook that enable experiential learning.

BioBuilder also works directly with district and community leaders to identify potential roadblocks to narrow the gap between science innovation and science education -- at least for biology - across the U.S., and better match the skill of our nation's workforce to the needs of the synthetic biology industry. Learn more by visiting

About BioMADE:

Launched in 2021, BioMADE is a Manufacturing Innovation Institute sponsored by the U.S. Department of Defense. By supporting the development of biomanufacturing technologies, BioMADE and its network of 150+ members across 29 states are strengthening American competitiveness, creating a more resilient supply chain, and helping the U.S. becoming more self-sufficient. Learn more about BioMADE by visiting

About ETSU:

East Tennessee State University (ETSU) is a public research university in Johnson City, Tennessee. It is the fourth largest university in the state with nearby off-campus centers. It hosts the James H. Quillen College of Medicine, often ranked as one of the top schools in the United States for rural medicine and primary care education; the Bill Gatton College of Pharmacy, the College of Nursing, the College of Public Health, and the recently formed College of Clinical and Rehabilitative Health Sciences. Learn more about ETSU at

About Ars Biotechnica:

Ars Biotechnica is a public nonprofit corporation with the goal of teaching high school students and teachers about synthetic biology. They publish BioTreks, the first international synthetic biology journal to be authored and reviewed by high school students. The journal is intended to give participating students the valuable experiences of writing and evaluating scientific papers, while offering them opportunities to share their own synthetic biology ideas, techniques, and results in a professionally edited, online publication. Learn more by visiting

About Daicel Arbor Biosciences:

Daicel Arbor Biosciences, a subsidiary of Chiral Technologies, Inc. (part of Daicel Corporation), is a biotech company that is specialized in targeted Next Generation Sequencing (NGS), in situ hybridization probe design, and cell-free protein expression. Their products and services have been utilized in broad applications in genomics, cytogenetics, and synthetic biology. They have served customers in plant, animal, human, bacteria, and virus areas for more than fifteen years. Learn more by visiting

Related link:

This news story was published by the Neotrope® News Network - all rights reserved. ID:NEO2022

Education and Schools, Free News Articles, NonProfit and Charities

Tens of Thousands of Researchers Celebrated During 13th National Postdoc Appreciation Week

ROCKVILLE, Md. -- The National Postdoctoral Association (NPA) today kicked off the 13th annual National Postdoc Appreciation Week (NPAW), taking place today through Friday. NPAW is the nation's largest celebration of postdoctoral scholars who serve at more than 300 institutions, acknowledging the significant contributions "postdocs" make to research, innovation and scientific discovery. This year's NPAW theme, "Finding Your Balance," recognizes the challenges postdocs face in balancing the rigors of their research positions with maintaining their health and wellness.

Postdocs are individuals holding doctoral degrees engaged in a temporary period of mentored research or scholarly training to gain needed skills to excel in their careers. These scholars conduct a large share of critical, cutting-edge research across all disciplines at universities, research institutions and industry members across the United States.

"Postdocs require exemplary discipline, focus, and balance to succeed in their challenging positions," said Tom Kimbis, J.D., executive director and chief executive officer of the NPA. "They are the backbone of science and research leadership in our country and deserve recognition throughout the year. Carving out a week to celebrate their remarkable work ethic and achievements is the least we can do."

The contribution of the roughly 70,000 U.S. postdocs, whose numbers are concentrated in the STEM fields and are instrumental to much of the early-stage research that occurs throughout the country, is often overlooked, as the academic postdoc is neither a student nor a faculty member. Yet, postdocs represent the highest-educated individuals in our society and drive innovation daily.

"Many don't realize that thousands of postdocs work in the social sciences - from economics to psychology - and go onto leadership positions in government, industry, and non-profit organizations," commented Stephanie Eberle, M.Ed., executive director of BioSci Careers at Stanford University. "Like those in the physical sciences, their roles are critical to societal growth and innovation."

Since its founding by the NPA in 2009, NPAW has grown into a truly national event, with universities, medical centers, industry members, and others hosting events this week to acknowledge the contributions of postdocs. Popular events during NPAW include professional and career development workshops, networking activities, and social events celebrating the immense contribution of postdocs to our nation's thought leadership. This year, roughly 40 free national events are open to all postdocs, in addition to local events happening on campuses across the nation.

NPAW 2022 is anchored by a kickoff event with opening remarks by Sharon Milgram, Ph.D., director of the Office of Intramural Training & Education (OITE) at the National Institutes of Health (NIH), and a panel discussion, featuring Robert Hable, Ph.D., innovation and product commercialization coordinator at BASF; Inge Hansen, Psy.D., clinical psychologist and director of well-being at Stanford University; and Yen Teng Tai, Ph.D., postdoctoral researcher at Penn State University College of Medicine. The discussion will focus on challenges early career researchers face, lessons learned from their own struggles, and a framework for postdocs to build better balance in their professional lives as they navigate their career progression.

A calendar of 2022 NPAW events can be found at

This year, NPAW is made possible by NPA Distinguished Partner, Gallagher Insurance, and NPA Gold Partner, Proteintech.

The NPA is a national charitable and educational non-profit association headquartered in Rockville, Maryland, that seeks to improve the postdoctoral experience by supporting a culture of inclusive connection. At the individual, organizational, and national levels, the NPA facilitates enhanced professional growth, raises awareness, and collaborates with stakeholders in the postdoctoral community. Membership in the NPA is open to all organizations and individuals interested in advancing the interests of postdocs in the United States.

Affiliate membership in the NPA for most postdocs is free and available at

To support NPA and its charitable mission to assist postdocs, please visit or text NPAW2022 to 44-321.

Related link:

This news story was published by the Neotrope® News Network - all rights reserved. ID:NEO2022

Business, Drugs and Pharmaceuticals, Free News Articles

Kalyagen Announces Attendance and Speaking Engagement at 8th Annual Biohacking Conference

AUSTIN, Texas -- Kalyagen is pleased to announce that it will be attending and its founder, Christian Drapeau, will be speaking at the upcoming 8th Annual Biohacking Conference. The conference, which is completely sold out, will be held September 15-17 at The Beverly Hilton in Beverly Hills, California.

"The Biohacking Conference will be an ideal opportunity to introduce STEMREGEN directly to an audience whose core focus is to tap into the body's innate ability to repair," said Christian Drapeau. "We are eager to meet and collaborate with the leaders of the biohacking movement."

STEMREGEN® is a unique and patent-pending blend of proprietary plant-based extracts documented to increase the number of circulating stem cells by stimulating Endogenous Stem Cell Mobilization (ESCM). Ingredients in STEMREGEN® have been investigated in more than eight studies for their effect on stem cell function, of which five were randomized, double-blind, placebo-controlled human clinical trials. STEMREGEN® has wide application in anti-aging and overall health maintenance.

"The link between a lower number of circulating stem cells and the development of age-related diseases has been well studied with numerous degenerative conditions, including diabetes, cardiovascular diseases, atherosclerosis, Alzheimer's disease, rheumatoid arthritis, pulmonary diseases, erectile dysfunction, and kidney disease," continued Mr. Drapeau. "From a therapeutic standpoint, increasing the number of circulating stem cells has been documented to enhance tissue repair or improve the course of disease formation in many degenerative conditions and overall health and well-being."

About Kalyagen:

Austin-based Kalyagen® was founded by Christian Drapeau, author of the bestseller Cracking the Stem Cell Code. Kalyagen® is a leader in the research and development of natural products aimed at supporting stem cell function of the body. Stem cells constitute the natural repair system of the body, and stem cell enhancers have been documented to strongly contribute to improving health and quality of life. STEMREGEN® is the first stem cell enhancer product developed by Kalyagen®. STEMREGEN® is a unique blend of proprietary plant-based extracts documented to support Endogenous Stem Cell Mobilization and provide other health benefits.

For more information, please visit our website:


Biomics, LLC (dba Kalyagen®)

Herbert Dogan, Chief Marketing Officer (310-433-8072)

Social media: @kalyagen #kalyagen #christiandrapeau #stemcellchristian #stemregen #stemcells #stemregeneffect #stemthetideoftime #stemthetide #biohacking

Disclaimer: None of the statements contained in this press release have been evaluated by the U.S. Food and Drug Administration. The products and information in the release are not intended to diagnose, treat, cure or prevent any disease.

Related link:

This news story was published by the Neotrope® News Network - all rights reserved. ID:NEO2022

Business, Free News Articles, Funding and Investment, General Editorial

BabyLiveAdvice Announces $1.1M Seed Investment to Improve Maternal-Infant Health Outcomes

CALABASAS, Calif. -- BabyLiveAdvice™, the leading virtual maternal telehealth provider, announced the completion of a $1.1 million seed investment led by Venn Ventures and Synergen Technology Labs. BabyLiveAdvice, founded by CEO Sigi Marmorstein, RN, PHN, MSN, FNP-BC, partners with healthcare providers and health systems to support coordinated, comprehensive prenatal, postpartum, and infant care anywhere by closing the care gaps experienced by expecting and new parents. The result is reduced complications and better outcomes for parents and babies.

Participating strategic investors span the healthcare ecosystem, including

* Venn Ventures, venture capital group,

* Synergen Technology Labs, technology innovators,

* Ob Hospitalist Group (OBHG) the nation's largest and only dedicated OB hospitalist provider,

* CareFirst BCBS, payer organization, and

* LifeBridge Health, hospital system.

"Providing safe and timely care to pregnant people and infants has always been a tremendous challenge," said Marmorstein. "Now, with decreasing outpatient and inpatient care capacities, related to provider burnout and shortage, maternal-infant care gaps are growing, resulting in worsening outcomes for parents and babies.

"BabyLiveAdvice's unique approach enables it to reduce these gaps and improve outcomes to enhance, not replace, the current standard of care."

BabyLiveAdvice had served over 40,000 parents, including Hispanic, Black, Navajo Nation, and other historically underserved populations. Through research and pilots, BabyLiveAdvice has demonstrated improved clinical outcomes, decreased emergency room use, reduced readmissions, and fewer postpartum complications.

Marmorstein explained how BabyLiveAdvice, "provides services that support marginalized, remote communities at a fraction of the cost with improved outcomes. We are the only company on the market that can support the entire pregnancy journey in one place from the comfort of the user's home without increasing the provider burden. With BabyLiveAdvice, babies now come with instructions."

Users have access to a network of resources and support for their journey to parenthood, including nurses, nurse-practitioners, doulas, lactation specialists, socialworkers, mental health providers, nutritional specialists, care coordinators, diabetic specialists, and virtual group education classes.

BLA provides users with virtual, live maternal education classes that support self-care and self-advocacy. Users receive significantly improved maternal-infant education in lactation, proper nutrition, mental health, weight management, blood pressure and blood sugar control, and other benefits.

"Maternal health is often overlooked and is an area of healthcare ripe for innovation benefitting both parents and children," said Melissa Larson Youngblood, BabyLiveAdvice Board Member and Co-Founder and Partner at Venn Ventures, which co-led the investment round. "It was easy to invest in BabyLiveAdvice and Sigi as a women entrepreneur. The company is mature, has a strong pipeline, and has tens of thousands of users across the nation."

BabyLiveAdvice leverages a VSee-built, customized telehealth solution that is HIPAA-compliant, featuring EHR integration, telemonitoring capabilities, chat functionality, and group or one-on-one consultations. All consultations are documented, and notes are shared with the patient's medical provider through seamless EHR integration to assure medical and supportive care are well aligned.

"Through our BabyLiveAdvice partnership, we look forward to providing new maternal care resources to our patients and hospital partners," said Dr. Amy VanBlaricom, OBHG's Chief Clinical Officer and BabyLiveAdvice board member. "We are especially excited about BabyLiveAdvice's potential to positively impact patients with access to care challenges and the minority populations we serve. BabyLiveAdvice aligns with OBHG's mission of saving the lives of mothers and babies regardless of location, race, or economic status. Supporting patients throughout all phases of pregnancy, including the prenatal and postpartum stages, is so important in closing gaps in care."

BabyLiveAdvice partners include March of Dimes, Johnson and Johnson, The National Black Doulas Association, LifeBridge Health Sinai Hospital in Baltimore, Huntington Health, AltaMed, among others.

For media queries and BLA partnerships contact David Marmorstein:

About BabyLiveAdvice:

BabyLiveAdvice is a woman and nurse-founded company with the mission to close the care gaps in maternal childcare and reduce maternal and infant morbidity and mortality around the world. BabyLiveAdvice has helped tens of thousands of parents to get one-on-one support and education from a caring provider in their language. Its mission is to help parents and improve the statistics surrounding pregnancy, births, and maternal wellbeing.

Learn more:


Related link:

This news story was published by the Neotrope® News Network - all rights reserved. ID:NEO2022

Business, Free News Articles, Funding and Investment

Proteios Technology, Inc. Awarded $1.6 Million NIH SBIR Grant to Commercialize its Multivariate Cell Isolation Technology

SEATTLE, Wash. -- Proteios Technology, Inc. is pleased to announce it's received a $1.6 million SBIR Phase II grant from the National Institutes of Health (NIH) to commercialize its multivariate (parallel) cell isolation technology. Grant funds will be used to extend Proteios' cell isolation kits to include up to 20 of the most common cell types currently used in cell therapy development.

Cell biology is complex. And conducting experiments on an isolated population of cells, rather than a heterogeneous mix, is a common approach to reduce experimental complexity. Cell isolation allows cell biologists to confidently attribute observed effects and responses to a particular cell type.

Specifically, Proteios' multivariate cell isolation technology provides high-performance, antibody- and magnetic bead-free isolation of cell types in fewer than 30 minutes. This is a big reduction in time compared to currently available methods, while meeting or exceeding cell yield, purity and viability.

Proprietary Proteios Chimeras will be designed and developed to bind to each of the 20 target cell types with high specificity and selectivity through a combination of robotic biological screening, Machine Learning (ML) and Molecular Dynamics (MD) simulation.

Proteios will also incorporate Proteios Chimeras into its cGMP cell therapy manufacturing device - a bench prototype funded under contract by the National Cancer Institute (NCI). The device provides end-to-end manufacturing of cell therapies in a closed and fully-automated system with concise control over the multiple cell types that form the basis of cell therapy formulations. Proteios Chimeras will be a major component of consumables for the cGMP cell therapy manufacturing device.

"It's believed that the effectiveness of cellular therapeutics can be improved by the addition/removal of certain secondary cell types," Bob Snyder, Ph.D., co-founder and CEO of Proteios Technology, says. "Proteios' cell isolation technology will provide for the parallel enrichment and/or depletion of any cell type as new cell therapy formulations are investigated, reducing the vein-to-vein time and overall manufacturing cost."

Proteios is also preparing for the immediate commercial release of its research-scale recombinant protein purification kits which will provide a viable alternative to His Tag technology, unusable with about 20 percent of proteins of interest.

Initially, Proteios will launch two kits based on a proprietary affinity tag and a silica-based resin for:

1 - high-expressing proteins; and

2 - low-expressing proteins.

To learn more:

About Proteios Technology:

Proteios Technology is a leading provider of products and services dedicated to supporting the discovery of advanced therapeutics and their efficient manufacturing. Its innovative solutions support research at all levels from discovery and translational research to cGMP manufacturing and companion diagnostics. Its technologies enable the multivariate (parallel), tag-free isolation of any biological, including proteins/biopharmaceuticals, cell types, antibodies and viruses. Proteios' research-scale kits enable the discovery of new advanced therapeutics. And the inherent scalability of the technology allows the same methodology to be used in the manufacturing of advanced therapeutics and dramatically reduces the time required for process development.

Proteios is driven by the goal to lower the cost of healthcare and to provide advanced therapeutics to a larger patient population. It's located in the heart of Seattle and adjacent to some of the world's leading cell therapy research institutes - including the Fred Hutchinson Cancer Research Center, Seattle Children's Research Institute and the Seattle Cancer Care Alliance.

Related link:

This news story was published by the Neotrope® News Network - all rights reserved. ID:NEO2022

Business, Free News Articles

Modern Foot & Ankle Opens New Clinic, Offers Evening Hours In Wesley Chapel

WESLEY CHAPEL, Fla. -- Modern Foot & Ankle is moving on up-to Wesley Chapel. Today the Central Florida podiatric group expands further into Pasco County by launching its eleventh clinic.

Ryan Haaksma, DPM, relocated from Chicago to bring his medical expertise to the group's newest location. He says he is excited to trade in the snow for a warm climate and friendly faces.

"Wesley Chapel is a rapidly growing community with a large family presence," said Dr. Haaksma. "There are a lot of outdoor activities. It's a challenging but rewarding opportunity to use the techniques I've learned to keep everyone walking pain-free."

Dr. Haaksma trained at one of the top orthopedic systems in the Midwest and under some of the most respected foot and ankle surgeons in the country at Rush University Medical Center. There, he learned a wide range of advanced options for conservative treatment and surgical intervention.

Now, by joining Modern Foot & Ankle, Dr. Haaksma has the support to deliver the highest quality care.

"Modern Foot & Ankle provides the infrastructure to allow me to practice with the most up-to-date technology to treat patients efficiently and obtain the best outcomes," he said.

From an early age, Dr. Haaksma knew he wanted to be in medicine. One of his first jobs was as a podiatric assistant.

"At the podiatry office I worked at, I had some wonderful mentors who took me under their wing," he said. "With their guidance, I realized how rewarding and beneficial a career in podiatry could be."

Dr. Haaksma says it's a great feeling of accomplishment to have worked his way from the bottom to the top.

"Besides my beautiful family, it is what I'm most proud of," he added.

The clinic is located in the plaza at 5841 Argerian Dr. in Wesley Chapel. Dr. Haasma offers evening hours because he believes creating an experience based on convenience and ease is a key component of a patient-centric approach, in addition to a welcoming demeanor.

"My greatest strength is listening to my patients and working together to come up with a treatment plan that works best for their goals," he said. "The most rewarding part of being a podiatrist is meeting a patient who's seen multiple providers without ideal results and being able to provide them with the results they've been wanting for years."

Patients who would like to schedule an appointment with Dr. Haaksma can book online at or call 1-844-MODERN9.

About Modern Foot & Ankle(r)

Through Big-City Technology. Small-Town Care.(r) Modern Foot & Ankle is reshaping the patient experience and curating a progressive model for podiatric healthcare. Our physicians provide comprehensive medical and surgical solutions for foot and ankle conditions in clinics across Central Florida. With 24/7 online booking and check-in, extended office hours, advanced on-site equipment, and cutting-edge treatment options, Modern Foot & Ankle serves patients efficiently, comfortably, and on their schedule. For more information, visit

Related link:

This news story was published by the Neotrope® News Network - all rights reserved. ID:NEO2022

Business, Free News Articles

Spodak Dental Group Earns Nationwide Invisalign® Provider’s Highest Honor, VIP: Diamond Plus

DELRAY BEACH, Fla. -- Spodak Dental Group has been named a VIP: Diamond Plus Provider of Invisalign® for 2022, which is the highest honor on the Invisalign® provider rankings.

There are only about 30 general dentists in North America who have earned the VIP: Diamond Plus distinction, and this elite designation is rewarded to those practitioners who provide unparalleled results in terms of treating patients with the best braces alternative system in the world. There are more than 40,000 Invisalign providers in the United States, but only less than 1% of those perform well enough to be named a VIP: Diamond Plus provider.

"It's an amazing honor to earn this coveted distinction, but we are more so excited for our family of patients and partnering with them on their smile journey. We are proud to be able to provide unparalleled dental care and help them achieve the straight and healthy smile of their dreams, all by offering this comfortable, proven and effective teeth-straightening method," said Dr. Craig Spodak, general dentist at Spodak Dental Group.

VIP: Diamond Plus status is the Top 1% status that an Invisalign Provider can earn, as it requires that an office completes 200 cases every six months. The accreditation comes from Invisalign, and it gives a clear indication of an office's experience and expertise working with the Invisalign system. To date, the Spodak Dental Group team has successfully treated more than 2,300 patients.

Spodak Dental Group is the only general dental office to earn the VIP: Diamond Plus status in Palm Beach, Broward and Martin Counties. The team of dentists conveniently offers current and future new patients both Invisalign® Adult and Teen treatments, and provides virtual appointments for those patients who wish to avoid in-office appointments.

Invisalign® effectively treats a wide variety of cases, including crowding, spacing, crossbite, overbite and underbite, and consists of smooth, comfortable plastic aligners instead of sharp metal, reducing irritation on your teeth and gums.

In addition to being a VIP: Diamond Plus Provider, the Spodak Dental Group uses the iTero® Digital Scanning System to provide great quality of care and comfort for their patients. The System eliminates the need for messy putty in the patient's mouth by creating a 3-D digital impression of his/her teeth. The System offers a faster and more comfortable experience with more accurate results, which delivers a more precise fit for the Invisalign® aligners.

Spodak Dental Group is currently helping patients begin their Invisalign® treatment for $0 down and $243 per month for 24 months, interest free. Average treatment time at the Spodak Dental Group is 10 months for adults, which is significantly less than traditional metal braces, in addition to being less expensive than braces.

The Spodak Dental Group, a 2017 Inc. 5000 honoree, has evolved to become South Florida's premier, comprehensive dental facility, and comprises a world-class association of dental professionals poised to provide full-service dental care second-to-none in both scope and skill. The Spodak Dental Group team includes General and Restorative Dentists, Endodontists, Periodontists, Board Certified Oral and Maxillofacial Surgeons, Master Ceramic Artists and Anesthesiologists, as well as one of the nation's only in-office dental labs.

Spodak Dental Group is located at 3911 W. Atlantic Ave. Call or text (561) 303-2413 or visit for more information or to schedule a virtual or in-office appointment.

Related link:

This news story was published by the Neotrope® News Network - all rights reserved. ID:NEO2022